Comparative lessons in regenerative medicine readiness: learning from the UK and Japanese experience

被引:7
|
作者
Umemura, Maki [1 ]
Morrison, Michael [2 ,3 ,4 ]
机构
[1] Cardiff Univ, Cardiff Business Sch, Int Business, Aberconway Bldg,Colum Dr, Cardiff CF10 3EU, Wales
[2] Univ Oxford, Ctr Hlth Law & Emerging Technol, Social Sci, Fac Law, Ewert House,Banbury Rd, Oxford OX2 7DD, England
[3] Univ Oxford, Inst Sci Innovat & Soc, Sch Anthropol, 51-53 Banbury Rd, Oxford OX2 6PE, England
[4] Univ Oxford, Museum Ethnog, 51-53 Banbury Rd, Oxford OX2 6PE, England
基金
英国经济与社会研究理事会;
关键词
Japan; regenerative medicine; regenerative readiness; sociotechnical systems; technology adoption; UK; SOCIOTECHNICAL SYSTEMS; UNITED-STATES; CELL THERAPY; HEALTH-CARE; STEM-CELLS; CHALLENGES; INNOVATION; REIMBURSEMENT; LANDSCAPE; PRODUCTS;
D O I
10.2217/rme-2020-0136
中图分类号
Q813 [细胞工程];
学科分类号
摘要
This paper explores how 'regenerative readiness' varies between different national research and healthcare systems. Here, 'readiness' refers to both the readiness of a given technology and the ability of a given setting to adopt a new technology. We compare two settings that have taken active yet dissonant approaches to improve readiness: the UK and Japan. Existing scholarship observes that disruptive technologies such as regenerative medicine require many adaptations to become useable and function along the principles of their design. We incorporate the sociotechnical systems framework to consider the range of adaptive measures taken across elements of the sociotechnical system for novel technological adoption. Building upon existing works on technology readiness and institutional readiness, we also expand the conceptualization of readiness toward system-wide readiness.
引用
收藏
页码:269 / 282
页数:14
相关论文
共 30 条
  • [1] Are there specific translational challenges in regenerative medicine? Lessons from other fields
    Gardner, John
    Faulkner, Alex
    Mahalatchimy, Aurelie
    Webster, Andrew
    REGENERATIVE MEDICINE, 2015, 10 (07) : 885 - 895
  • [2] Anticipating the clinical adoption of regenerative medicine: building institutional readiness in the UK
    Gardner, John
    Webster, Andrew
    Barry, Jacqueline
    REGENERATIVE MEDICINE, 2018, 13 (01) : 29 - 39
  • [3] Developing innovation governance readiness in regenerative medicine: lessons learned from the Macchiarini crisis
    McKelvey, Maureen
    Saemundsson, Rognvaldur J.
    REGENERATIVE MEDICINE, 2021, 16 (03) : 283 - 294
  • [4] Regenerative medicine, resource and regulation: lessons learned from the remedi project
    Ginty, Patrick J.
    Rayment, Erin A.
    Hourd, Paul
    Williams, David J.
    REGENERATIVE MEDICINE, 2011, 6 (02) : 241 - 253
  • [5] Regenerative medicine therapies: lessons from the kidney
    Davies, Jamie A.
    Murray, Patricia
    Wilm, Bettina
    CURRENT OPINION IN PHYSIOLOGY, 2020, 14 : 41 - 47
  • [6] Lessons from Developmental Biology for Regenerative Medicine
    Turner, Neill J.
    Keane, Timothy J.
    Badylak, Stephen F.
    BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS, 2013, 99 (03) : 149 - 159
  • [7] Leukemia: Lessons from the Japanese experience
    Finch, SC
    STEM CELLS, 1997, 15 : 135 - 139
  • [8] Regenerative Medicine of Epithelia: Lessons From the Past and Future Goals
    Maurizi, Eleonora
    Adamo, Davide
    Magrelli, Federica Maria
    Galaverni, Giulia
    Attico, Eustachio
    Merra, Alessia
    Maffezzoni, Maria Benedetta Rizzarda
    Losi, Lorena
    Genna, Vincenzo Giuseppe
    Sceberras, Virginia
    Pellegrini, Graziella
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [9] Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine
    Basu, Amitava
    Tiwari, Vijay K.
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [10] Vascularizing organogenesis: Lessons from developmental biology and implications for regenerative medicine
    Daniel, Edward
    Cleaver, Ondine
    ORGAN DEVELOPMENT, 2019, 132 : 177 - +